Table of content for "Idecabtagene car pos t" (HCPCS C9081)
General information on the “C9081” code
HCPCS Code: C9081
Long Description: Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Idecabtagene car pos t
Original information is taken from C9081 page
Pricing indicators
Pricing Indicator Code 1: 53 – Statute
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Statute Number: 1833(t)
Cross Reference Code 1: Q2055 ;
Coverage
Coverage: D – Special coverage instructions apply
Type of service
Berenson-Eggers Type of Service (BETOS): O1D – Chemotherapy
Type Of Service 1: 9 – Other medical items or services
Type Of Service 2: F – Ambulatory surgical center (facility usage for surgical services)
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20211001
Code Effective Date: 20220101
Termination Date: 20211231
Action Code: N – No maintenance for this code